Revenue of Lundbeck top products 2021-2023
Among products of Danish pharmaceutical company Lundbeck, the second highest revenue in 2023 was generated by Brintellix/Trintellix. The revenues from Brintellix/Trintellix reached roughly 4.3 billion Danish kroner that year. It was topped by Rexulti/Rxulti, with a revenue of 4.5 billion Danish kroner. H. Lundbeck A/S is a Danish pharmaceutical company founded in 1915 with its headquarter in Copenhagen. The key products produced by the company are pharmaceuticals for the nervous system.